Literature DB >> 11950157

The effects of altitude training are mediated primarily by acclimatization, rather than by hypoxic exercise.

B D Levine1, J Stray-Gundersen.   

Abstract

For training at altitude to be effective, it must provide some advantage above and beyond similar training at sea level. This advantage could be provided by: 1) acclimatization to altitude which improves oxygen transport and/or utilization; 2) hypoxic exercise which "intensifies" the training stimulus; or 3) some combination of both. Controlled studies of "typical" altitude training, involving both altitude acclimatization and hypoxic exercise have never been shown to improve sea level performance. This failure has been attributed to reduced training loads at altitude. One approach developed by Levine and Stray-Gundersen, called "living high-training low" has been shown to improve sea level performance over events lasting 8-20 minutes. This strategy combines altitude acclimatization (2,500 m) with low altitude training to get the optimal effect. The opposite strategy, "living low-training high" is proposed by Dr. Hoppeler in this debate. In defense of the primacy of the altitude acclimatization effect, data will be presented to support the following: 1). Living high-training low clearly improves performance in athletes of all abilities; 2). The mechanism of this improvement is primarily an increase in erythropoietin leading to increased red cell mass, VO2max, and running performance; 3). Rather than intensifying the training stimulus, training at altitude leads to the opposite effect--reduced speeds, reduced power output, reduced oxygen flux--and, following the principal of symmorphosis, is not likely to provide any advantage for a well trained athlete; 4). At the moderate altitudes used by most athletes, resting oxygen delivery to skeletal muscle is well preserved, arguing against any detrimental effect on "protein synthesis"; 5). It is possible however, that at significantly higher altitudes, acclimatization leads to appetite suppression, inhibition of protein synthesis, muscle wasting, excessive ventilatory work, and metabolic compensation that is NOT advantageous for a competitive athlete.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11950157     DOI: 10.1007/978-1-4757-3401-0_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  Drugs for increasing oxygen and their potential use in doping: a review.

Authors:  Aurelie Gaudard; Emmanuelle Varlet-Marie; Francoise Bressolle; Michel Audran
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Increases in .VO2max with "live high-train low" altitude training: role of ventilatory acclimatization.

Authors:  Daniel P Wilhite; Timothy D Mickleborough; Abigail S Laymon; Robert F Chapman
Journal:  Eur J Appl Physiol       Date:  2012-07-07       Impact factor: 3.078

3.  Molecular evolution of myoglobin in the Tibetan Plateau endemic schizothoracine fish (Cyprinidae, Teleostei) and tissue-specific expression changes under hypoxia.

Authors:  Delin Qi; Yan Chao; Yongli Zhao; Mingzhe Xia; Rongrong Wu
Journal:  Fish Physiol Biochem       Date:  2017-12-11       Impact factor: 2.794

4.  Changes of globin expression in the Japanese medaka (Oryzias latipes) in response to acute and chronic hypoxia.

Authors:  Agnes Wawrowski; Frank Gerlach; Thomas Hankeln; Thorsten Burmester
Journal:  J Comp Physiol B       Date:  2010-10-21       Impact factor: 2.200

Review 5.  Putative Role of Respiratory Muscle Training to Improve Endurance Performance in Hypoxia: A Review.

Authors:  Jesús Álvarez-Herms; Sonia Julià-Sánchez; Francisco Corbi; Adrian Odriozola-Martínez; Martin Burtscher
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566

6.  Discrepancy between cardiorespiratory system and skeletal muscle in elite cyclists after hypoxic training.

Authors:  Ryotaro Kime; Trine Karlsen; Shoko Nioka; Gwen Lech; Rolf Sæterdal; Joohee Im; Britton Chance; James Stray-Gundersen
Journal:  Dyn Med       Date:  2003-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.